Background illustration for clinical trials search

Anemia Clinical Trials

Browse 262 anemia clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1
Active & Responsive

Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia

for
Myelofibrosis; Anemia, Anemia, Myelofibrosis,
Location: New York NY, East Brunswick NJ, Philadelphia PA,
Sponsor: Disc Medicine, Inc

Sex: All

Age: 18+

Code: NCT05320198

Phase1, Phase2, Recruiting
Active & Responsive

A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease

for
Anemia, Sickle Cell, Healthy Volunteers
Location: Boston MA, New Haven CT, Philadelphia PA, Richmond VA,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT06481306

Phase1, Phase2, Recruiting
Active & Responsive

The Congenital Dyserythropoietic Anemia Registry (CDAR)

for
Congenital Dyserythropoietic Anemia (CDA)
Location: Cincinnati OH
Sponsor: Children's Hospital Medical Center, Cincinnati

Sex: All

Age: 0+

Code: NCT02964494

Recruiting
Active & Responsive

Study of DISC-0974-201 in Participants With IBD and Anemia

for
Inflammatory Bowel Disease (IBD), Anemia,
Location: Providence RI, Miami Lakes FL, Miami FL, Doral FL,
Sponsor: Disc Medicine, Inc

Sex: All

Age: 18+

Code: NCT07368972

Phase2, Recruiting
Active & Responsive

A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib

for
Myelofibrosis, Anemia
Location: Coral Springs FL, Houston TX
Sponsor: Takeda

Sex: All

Age: 18+

Code: NCT07623161

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

MRI as Noninvasive Innovative Approach in Detection and Monitoring of Malignant Oral Lesions in Fanconi Anemia Patients

for
Fanconi Anemia
Location: Minneapolis MN
Sponsor: University of Minnesota

Sex: All

Age: 18+

Code: NCT07649031

Recruiting
Active & Responsive

Targeting the Pathophysiology of Sickle Cell-Related Kidney Disease Using the SGLT2 Inhibitors, Empagliflozin

for
Sickle Cell Anemia (HbSS, or HbSβ-thalassemia0), Albuminuria
Location: Chicago IL
Sponsor: University of Illinois at Chicago

Sex: All

Age: 18 - 60

Code: NCT07175051

Phase2, Recruiting
Active & Responsive

Better Birth Outcomes Through Technology, Education, and Reporting

for
Pregnancy, Maternal Anemia, Pre-Term Birth,
Location: Columbus OH
Sponsor: Ohio State University

Sex: Female

Age: 18+

Code: NCT06261398

Recruiting
Active & Responsive

MT2023-20: Hematopoietic Cell Transplant With Reduced Intensity Conditioning and Post-transplant Cyclophosphamide for Severe Aplastic Anemia and Other Forms of Acquired Bone Marrow Failure.

for
Severe Aplastic Anemia,
Location: Minneapolis MN
Sponsor: Masonic Cancer Center, University of Minnesota

Sex: All

Age: 0 - 70+

Code: NCT06412497

Phase2, Recruiting
Active & Responsive

Post-operative Intravenous Iron to Treat Iron-deficiency Anemia in Patients Undergoing Cardiac Surgery

for
Chronic Iron Deficiency Anaemia, Cardiac Surgery
Location: Kingston, Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT06287619

Phase2, Recruiting
Active & Responsive

Effect of Accelerated Neuromodulation of Anterior Cingulate Cortex to Enhance Cognition in Older Adults With Mild Memory Problems

for
Mild Cognitive Impairment (MCI),
Location: Toronto
Sponsor: Rotman Research Institute at Baycrest

Sex: All

Age: 55 - 70+

Code: NCT07212504

Recruiting
Active & Responsive

A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)

for
Sickle Cell Disease
Location: The Bronx NY, Philadelphia PA, Easton PA, Baltimore MD,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 12 - 70+

Code: NCT06439082

Phase3, Recruiting
Active & Responsive

Effects of Hard Gum Chewing on Facial Soft Tissue Morphology

for
Face
Location: Farmington CT
Sponsor: UConn Health

Sex: All

Age: 20 - 40

Code: NCT07726511

Recruiting
Active & Responsive

Liquid Biopsy Evaluation and Repository Development at Princess Margaret

for
Cancer, Breast Cancer, Lung Cancer, Colon Cancer,
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT03702309

Recruiting
Active & Responsive

Comprehensive Assessment of Neurodegeneration and Dementia

for
Dementia, Mild Cognitive Impairment (MCI),
Location: Halifax, Quebec, Montreal, Toronto, Hamilton, London,
Sponsor: McGill University

Sex: All

Age: 50 - 70+

Code: NCT03402919

Recruiting
Active & ResponsiveNew

Aprepitant for the Treatment of CLIFAHDD

for
CLIFAHDD,
Location: San Antonio TX
Sponsor: The University of Texas Health Science Center at San Antonio

Sex: All

Age: 0+

Code: NCT07845825

Early_phase1, Recruiting
Active & Responsive

Craniomaxillofacial and Upper Extremity Allotransplantation

for
Face Injuries, Hand Injuries, Craniofacial Injuries,
Location: New York NY
Sponsor: NYU Langone Health

Sex: All

Age: 18 - 64

Code: NCT04057638

Recruiting
Active & Responsive

Carboplatin or Olaparib for BRcA Deficient Prostate Cancer

for
Metastatic Castrate Resistant Prostate Cancer,
Location: New York NY, Philadelphia PA, Washington D.C. DC,
Sponsor: VA Office of Research and Development

Sex: Male

Age: 18+

Code: NCT04038502

Phase2, Recruiting
Active & Responsive

Gene Correction in Autologous CD34+ Hematopoietic Stem Cells (HbS to HbA) to Treat Severe Sickle Cell Disease

for
Sickle Cell Disease
Location: New York NY, Columbus OH, St Louis MO, Los Angeles CA,
Sponsor: Kamau Therapeutics

Sex: All

Age: 12 - 50

Code: NCT04819841

Phase1, Phase2, Recruiting
Active & Responsive

Transplantation of Clustered Regularly Interspaced Short Palindromic Repeats Modified Hematopoietic Progenitor Stem Cells (CRISPR_SCD001) in Patients With Severe Sickle Cell Disease

for
Sickle Cell Disease
Location: Los Angeles CA, Oakland CA
Sponsor: Mark Walters, MD

Sex: All

Age: 12 - 35

Code: NCT04774536

Phase1, Phase2, Recruiting

What are Anemia clinical trials?

Anemia clinical trials rarely take a one-size-fits-all approach, since the condition itself can stem from so many different causes, like low iron, vitamin deficiencies, chronic illness, or inherited blood conditions. Each study usually zeroes in on a specific cause or type, testing ways to restore healthy red blood cell levels or address whatever's driving the deficiency in the first place.

Researchers also use this research to look at how anemia affects everyday life beyond blood test numbers, since fatigue and low energy can quietly impact work, activity levels, and overall wellbeing long before someone even realizes something's wrong.

The importance of clinical trials in Anemia research

Anemia is one of the most common blood conditions worldwide, yet its causes and impact vary so much from person to person that research has to work hard to keep up. Anemia research studies help fill that gap by studying different types of anemia individually, rather than approaching it as a single condition with one explanation.

This kind of research also helps connect the dots between anemia and other health conditions it's often tied to, like chronic kidney disease or pregnancy-related changes, giving researchers a fuller picture of how blood health fits into someone's overall wellbeing.

Article preview image

Iron deficiency is especially common during pregnancy. Learn more in our article

Iron Deficiency During Pregnancy: Symptoms, Risks, and Treatment Options

Who can participate in Anemia clinical trials?

Types of Anemia clinical trials

How to enroll in a clinical trial for Anemia